Inhaled particles and lung cancer, part B: paradigms and risk assessment.
about
Air pollution from traffic and cancer incidence: a Danish cohort studyAcute inflammatory responses of nanoparticles in an intra-tracheal instillation rat modelLung cancer in railroad workers exposed to diesel exhaustTitanium dioxide nanoparticles: a review of current toxicological dataAdvances in mechanisms and signaling pathways of carbon nanotube toxicityNeoplastic-like transformation effect of single-walled and multi-walled-carbon nanotubes compared to asbestos on human lung small airway epithelial cellsThe influence of hydrogen peroxide and histamine on lung permeability and translocation of iridium nanoparticles in the isolated perfused rat lungPollutional haze as a potential cause of lung cancerEvaluating the mechanistic evidence and key data gaps in assessing the potential carcinogenicity of carbon nanotubes and nanofibers in humansRisk Assessment of the Carbon Nanotube GroupPulmonary exposure to carbon black by inhalation or instillation in pregnant mice: effects on liver DNA strand breaks in dams and offspringRole of mutagenicity in asbestos fiber-induced carcinogenicity and other diseasesLung particle overload: old school -new insights?Potential toxicity and safety evaluation of nanomaterials for the respiratory system and lung cancerLung Cancer Incidence and Long-Term Exposure to Air Pollution from TrafficBiological and environmental interactions of emerging two-dimensional nanomaterials.Multiparametric approach for an exemplary study of laser printer emissions.Research strategies for safety evaluation of nanomaterials, part IV: risk assessment of nanoparticles.Comparison of oxidative properties, light absorbance, total and elemental mass concentration of ambient PM2.5 collected at 20 European sitesCarcinogenicity of ambient air pollution: use of biomarkers, lessons learnt and future directionsIron oxide nanoparticles induce oxidative stress, DNA damage, and caspase activation in the human breast cancer cell line.Relationship of pulmonary toxicity and carcinogenicity of fine and ultrafine granular dusts in a rat bioassayCharacterization and Cytotoxicity of PM<0.2, PM0.2-2.5 and PM2.5-10 around MSWI in Shanghai, ChinaExposure to ultrafine particles from ambient air and oxidative stress-induced DNA damage.NanoTIO(2) (UV-Titan) does not induce ESTR mutations in the germline of prenatally exposed female mice.Research strategies for safety evaluation of nanomaterials, part V: role of dissolution in biological fate and effects of nanoscale particles.Nanoparticles in drug delivery and environmental exposure: same size, same risks?Genotoxicity of poorly soluble particles.Risk assessment for biopersistent granular particles.Biopharmaceutics and therapeutic potential of engineered nanomaterials.Titanium dioxide nanoparticles induce DNA damage and genetic instability in vivo in miceDevelopment of in vitro systems for nanotoxicology: methodological considerations.Role of oxidative damage in toxicity of particulates.Zinc oxide nanoparticles in modern sunscreens: an analysis of potential exposure and hazard.Has nanotechnology led to improved therapeutic outcomes?Oxidatively damaged DNA in animals exposed to particles.Diesel engine exhaust: basis for occupational exposure limit value.Cytotoxicity and genotoxicity induced by coal and coal fly ash particles samples in V79 cells.Mechanisms of Multi-walled Carbon Nanotubes-Induced Oxidative Stress and Genotoxicity in Mouse Fibroblast Cells.Interleukin-1β-mediated suppression of microRNA-101 and upregulation of enhancer of zeste homolog 2 is involved in particle-induced lung cancer.
P2860
Q21245831-D516620D-2B8C-45A4-B463-0CC54A94C63CQ23909870-B6D05B80-706F-42DA-B1F1-A57FFDF7F4F1Q23912579-3BDB124E-2972-408D-8A92-A55BDC1E1F71Q23913609-78DB92D1-5D93-434F-B9AD-E24B3675DC6AQ23914875-D4FD31C6-917A-40F1-B3B0-964FC82592F3Q23917080-9264E490-87FD-4D5A-AD1D-06260D55DD6AQ24814544-E632683F-A17B-4256-B049-722E2A42EF97Q26775705-209C07DB-055E-4987-BA0D-96ABF0562511Q27908506-CEE2FB01-CD22-47D4-AFBB-8637925CE974Q28385675-D191E1C4-B731-44AA-9379-81A652E4255AQ28387144-77595B86-3BB5-43DA-ABEB-A00DDA2D38BAQ28389566-0D7771FA-3DD3-4FFD-A551-45D74415AB22Q28393158-6D0FD8E8-AA7C-4C8A-8C09-2AA215A58B9BQ29248491-1A55BF05-E846-46C2-969E-975CDCEAB60DQ29303077-DE393D42-55A1-462F-A9CA-223BE31C3069Q30736816-4F1534DE-A783-4D43-B1DE-AA81014EAF75Q34133746-4F5D0A4D-6D8C-437C-92ED-333008FBF67EQ34452887-07E901FA-1D57-437E-8633-97CF48FCD6EEQ34603098-F2BE3685-A34C-4113-AE59-D8B4F8966FB4Q35028952-00F17100-1D19-467F-AAB4-ACD0DE54F9ABQ35153046-A1321162-9EEA-41F0-9C39-05ABC5C43CFBQ35217507-2BA7C5E0-393F-4A1B-B274-C330C98E3A81Q35681370-D471D646-886E-4609-B7D1-E3DB06B9A76EQ35925392-00A382D1-41B0-4B60-99B8-C7B027FC8B31Q36164214-FD0DB430-4388-476A-A54E-8220685B147EQ36362072-B8216E7C-0E79-4E3C-9AC4-C49932638ECBQ36917908-82474107-3538-47EF-AD10-CCDFFCF7991AQ36948400-2AC00D73-A90B-430F-8AFB-5E2446E49939Q36948405-06D49728-8743-4816-861D-8B1DA314719CQ37273411-E698ACCD-7314-4478-9A8A-5EE5CAC593B1Q37414962-739C5000-9911-4A00-B6A3-BED613A2BE8FQ37570536-327F7C25-9CD7-4F48-80D2-D029B8784D15Q37626816-C3965F70-4DD2-48AE-B249-E7D4EE7897F2Q37783304-94005F96-2C2D-4A48-A235-FF6309A91407Q37970730-3FD50625-1FCD-4C83-87C2-D11CC57A8BAAQ38076465-C59DFBE5-61BD-4849-B025-FD83A6E5CFCEQ38668390-57D63F2B-3D4F-4077-9296-26A3FC2EC189Q38745869-F462AA1C-F0E7-4C2B-BC95-4ED6418BFD4DQ38872234-8258DCB4-37CA-4727-BC95-8C19C8FC744DQ38937458-C381E176-11F4-42F2-897F-979D253998C0
P2860
Inhaled particles and lung cancer, part B: paradigms and risk assessment.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Inhaled particles and lung cancer, part B: paradigms and risk assessment.
@ast
Inhaled particles and lung cancer, part B: paradigms and risk assessment.
@en
type
label
Inhaled particles and lung cancer, part B: paradigms and risk assessment.
@ast
Inhaled particles and lung cancer, part B: paradigms and risk assessment.
@en
prefLabel
Inhaled particles and lung cancer, part B: paradigms and risk assessment.
@ast
Inhaled particles and lung cancer, part B: paradigms and risk assessment.
@en
P2093
P2860
P356
P1476
Inhaled particles and lung cancer, part B: paradigms and risk assessment.
@en
P2093
Catrin Albrecht
Paul J A Borm
Roel P F Schins
P2860
P356
10.1002/IJC.20064
P577
2004-05-01T00:00:00Z